Agoracom Blog Home

Archive for the ‘All Recent Posts’ Category

Avicanna Inc. $AVCN.ca to Host Second Quarter 2020 Investor Conference Call $CRDL.ca $PCLO.ca $WEED.ca $ACB.ca

Posted by AGORACOM-JC at 6:46 PM on Friday, August 7th, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

TORONTO, Aug. 7, 2020 – Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that it has scheduled a conference call on Monday, August 17, 2020 at 9:00AM Eastern Time to discuss the results for its fiscal second quarter ended June 30, 2020. Aras Azadian, Chief Executive Officer and Davender Sohi, Chief Financial Officer, will host the call and a question and answer period. The Company will report its financial results for the second quarter after the close of markets on Friday, August 14, 2020.

            Conference Call Details

DATE:                                           August 17, 2020                                   
TIME:  9:00 AM Eastern Time
  
CONFIRMATION #:                             64751998
  
TORONTO:                                           416-764-8659
NORTH AMERICAN TOLL FREE:         1-888-664-6392
GERMANY TOLL FREE:   08007240293
COLOMBIA TOLL FREE:      018005184036
  
REPLAY TORONTO:                             416-764-8677  
REPLAY NORTH AMERICA:    1-888-390-0541 
REPLAY ENTRY CODE:   751998#
REPLAY EXPIRATION DATE:               August 24, 2020

About Avicanna Inc.

Avicanna is an Ontario, Canada based corporation focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products through its two main business segments, cultivation and research and development.

Avicanna’s two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia are the base for Avicanna’s cultivation activities. These two companies are licensed to cultivate and process cannabis for the production of cannabis extracts and purified cannabinoids including cannabidiol (CBD) and tetrahydrocannabinol (THC).

Avicanna’s research and development business is primarily conducted out of Canada at its headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto. Avicanna’s scientific team develops products, and Avicanna has also engaged the services of researchers at the Leslie Dan Faculty of Pharmacy at the University of Toronto for the purpose of optimizing and improving upon its products.

Avicanna’s research and development and cultivation activities are focused on the development of its key products, including plant-derived cannabinoid pharmaceuticals, phyto-therapeutics, derma-cosmetics, and Extracts (defined as plant-derived cannabinoid extracts and purified cannabinoids, including distillates and isolates), with a goal of eventually having these products manufactured and distributed through various markets.

Stay Connected

For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email at [email protected].

Cautionary Note Regarding Forward-Looking Information and Statements

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions, estimates and assumptions of management in light of management’s experience and perception of historical trends, current conditions and expected developments at the date the statements are made, such as current and future market conditions, the current and future regulatory environment and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual information form dated April 15, 2020 (the “AIF“) and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com. The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

SOURCE Avicanna Inc.

Labrador Gold $LAB.ca Announces Start of Exploration at Kingsway $RIO.ca $WHM.ca $SIC.ca $NXS.ca $NVO.ca

Posted by AGORACOM-Eric at 9:24 AM on Thursday, August 6th, 2020

TORONTO, Aug. 06, 2020 (GLOBE NEWSWIRE) — Labrador Gold Corp. (TSX-V: LAB | OTCQB: NKOSF) (“LabGold” or the “Company”) is pleased to announce that its field crew has arrived in Gander and started the 2020 exploration program on the Kingsway Property.

LabGold’s work program will initially focus on following up known gold anomalies identified from previous work on the three licenses. Soil sampling has begun on a high priority target that covers a 3km long anomaly of gold in heavy mineral concentrates with values from <5ppb to 89ppm (89g/t Au) that runs along the interpreted trace of the Appleton fault zone. Geological mapping and prospecting of anomalous areas and known showings is also underway.

Up to 10,000 soil samples and 250 km of ground magnetics/VLF-EM are planned for the property and are expected to take about six weeks to complete. We intend to hit the priority areas with known gold anomalies first so that the results of these surveys, together with the results of the geological mapping and prospecting can be used to plan a first phase fall drilling program.

Concurrently with the field work, we are working on a structural compilation of the district. This compilation will allow us to more efficiently target areas for detailed mapping and prospecting based on a better understanding of the role of primary and secondary structures on the localization of gold mineralization.

“It feels good to get boots on the ground at Kingsway which we believe to be the most strategically located property in the Gander gold district relative to New Found Gold’s recent discovery,” said Roger Moss, President and CEO. “Our focus on soil geochemistry and mag/VLF to define structures and potential alteration zones is consistent with what has worked well in the past and we expect to generate numerous targets along the major structures for drill testing.”

“It’s good to see the Kingsway Project moving along. Our limited 2019 deeper soil program over anomalous gold in till and vegetation samples proved successful in outlining new gold targets that will be followed up during this season’s work,” said Shawn Ryan, Technical Advisor to LabGold. “Based on last year’s success, the proposed larger 10,000 sample soil program covering existing gold in till and vegetation samples should produce some nice new gold anomalies leading to new drill targets.”

Roger Moss, PhD., P.Geo., is the qualified person responsible for all technical information in this release.

The Company gratefully acknowledges the Newfoundland and Labrador Ministry of Natural Resources’ Junior Exploration Assistance (JEA) Program for its financial support for exploration of the Kingsway property.

About Labrador Gold:

Labrador Gold is a Canadian based mineral exploration company focused on the acquisition and exploration of prospective gold projects in Eastern Canada.

In early March 2020, Labrador Gold acquired the option to earn a 100% interest in the Kingsway project in the Gander area of Newfoundland. The property is along strike to the northeast of New Found Gold’s discovery of 92.86 g/t Au over 19.0 metres on their Queensway property. (Note that mineralization hosted on adjacent or nearby properties is not necessarily indicative of mineralization hosted on the Company’s property). In early July 2020, the Company signed an option agreement to acquire a third license to add to the property package which now covers approximately 77 km2. The three licenses comprising the Kingsway project cover approximately 16km of the Appleton fault zone which is associated with gold occurrences in the region, including the New Found Gold discovery. Historical work over the area covered by the Kingsway licenses shows evidence of gold in till, vegetation, soil, stream sediments, lake sediments and float. Infrastructure in the area is excellent located just 18km from the town of Gander with road access to the project, nearby electricity and abundant local water.

The Hopedale property covers much of the Hunt River and Florence Lake greenstone belts that stretch over 80 km. The belts are typical of greenstone belts around the world but have been underexplored by comparison. Initial work by Labrador Gold during 2017 show gold anomalies in soils and lake sediments over a 3 kilometre section of the northern portion of the Florence Lake greenstone belt in the vicinity of the known Thurber Dog gold showing where grab samples assayed up to 7.8g/t gold. In addition, anomalous gold in soil and lake sediment samples occur over approximately 40 kilometres along the southern section of the greenstone belt (see news release dated January 25th 2018 for more details). Labrador Gold now controls approximately 57km strike length of the Florence Lake Greenstone Belt.

The Ashuanipi gold project is located just 35 km from the historical iron ore mining community of Schefferville, which is linked by rail to the port of Sept Iles, Quebec in the south. The claim blocks cover large lake sediment gold anomalies that, with the exception of local prospecting, have not seen a systematic modern day exploration program. Results of the 2017 reconnaissance exploration program following up the lake sediment anomalies show gold anomalies in soils and lake sediments over a 15 kilometre long by 2 to 6 kilometre wide north-south trend and over a 14 kilometre long by 2 to 4 kilometre wide east-west trend. The anomalies appear to be broadly associated with magnetic highs and do not show any correlation with specific rock types on a regional scale (see news release dated January 18th 2018). This suggests a possible structural control on the localization of the gold anomalies. Historical work 30 km north on the Quebec side led to gold intersections of up to 2.23 grams per tonne (g/t) Au over 19.55 metres (not true width) (Source: IOS Services Geoscientifiques, 2012, Exploration and geological reconnaissance work in the Goodwood River Area, Sheffor Project, Summer Field Season 2011). Gold in both areas appears to be associated with similar rock types.

The Company has 91,584,175 common shares issued and outstanding and trades on the TSX Venture Exchange under the symbol LAB.

For more information please contact:             

Roger Moss, President and CEO      Tel: 416-704-8291

Or visit our website at: www.labradorgold.com

Twitter:@LabGoldCorp

Agoracom Welcomes Candente Copper with Canariaco Deposit, Included in Goldman Sachs 84 Top Copper Projects Worldwide $DNT.ca $CN.ca $FCX $BHP $TECK.ca

Posted by AGORACOM-Eric at 9:18 AM on Thursday, August 6th, 2020

CANDENTE HIGHLIGHTS:

  • Canariaco Included in Goldman Sachs 84 Top Copper Projects Worldwide
    • Cañariaco in Lowest Quartile of Copper Industry Production Costs
    • Definitive Feasibility 50% Complete
    • Higher grade throughput of 0.54% CuEqMill Feed Grade during first 3 years
    • Rising Copper and Gold Prices Impacting 2011 PFS
  • Fortescue Metals Group Ltd. owns 19.92% interest
    • Joint technical committee created to identify optimum strategy for Cañariaco development

Project Highlights:

Cañariaco Norte is a 100% owned feasibility-stage porphyry copper deposit

  • A single, contiguous, open-pit mineable deposit of 7.5B pounds Measured and Indicated,
  • 1.4B pounds Inferred Porphyry Copper Deposit
  • Annual production of 262,000,000lbs of copper, 39,000 oz gold & 911,000 oz silver over initial mine life of 22 yrs(@ 95,000 tpd)

Pre-Feasibility Study

  • NPV of US $922M and IRR of 17.3% (using US$2.25 copper and an 8% discount rate)
  • Payback of preproduction capital in 4.4 years (after-tax)
  • Copper Production of 262,000,000 pounds per year
  • Initial Mine life of 22 years+
  • Throughput rate of 95,000 tonnes per day
  • Operating costs of US$0.988 per pound of copper (including onsite/offsite costs, taxes and byproduct credits)
  • Minimal infrastructure required, excellent locations for all site facilities, close to existing highway (42km away) and power grid (57km away) & abundant water at site
  • Very strong community & regional support

The Cañariaco Norte Copper Project

  • Canariaco in Top 80 Deposits slated for Development according to Goldman Sachs
    • 42 in South America –Cañariaco Included
    • Cañariaco in Lowest Quartile of Copper Industry Production Costs
  • Large scale porphyry copper–gold-silver deposit in Northern Peru
  • 7.5B pounds Measured and Indicated, plus 1.4B pounds Inferred Porphyry Copper Deposit
  • Deposit and Scope of Project Development well defined by Pre-Feasibility Studies in 2011
  • Annual production of 262,000,000lbs of copper, 39,000 oz gold & 911,000 oz silver over initial mine life of 22 yrs(@ 95,000 tpd)
  • Operating costs of US$0.988 per pound of copper (including onsite/offsite costs, taxes and byproduct credits
  • Strong Government support

Resource and Mine Plan

123 Million tonnes @ 0.58% Cu Eq (0.4% Cu cutoff) Measured

752 Million tonnes @ 0.52% Cu Eq (0.3% Cu cutoff) M & Indicated

1.0 Billion tonnes @ 0.46% Cu Eq(0.2% Cu cutoff) M & I

Current Mine Plan 728.2 Million tonnes @ 0.46% CuEqMill Feed Grade

  • Higher grade throughput of 0.54% CuEqMill Feed Grade during first 3 years

Canariaco Price Sensitivities Chart

  • Rising Copper and Silver Prices dramatically Project Economics
  • Based on 2011 Pre-Feasibility Progress Report

Lomiko Investment $LMR.ca Promethieus Ventures N.V. To List On The Dutch Caribbean Stock Exchange With Ticker DCSX:TECH $CJC.ca $SRG.ca $NGC.ca $LLG.ca $GPH.ca $NOU.ca

Posted by AGORACOM-Eric at 8:56 AM on Thursday, August 6th, 2020

 Vancouver, B.C., Aug. 06, 2020 (GLOBE NEWSWIRE) — Lomiko Metals Inc. (“Lomiko”) (TSX-V: LMR, OTC: LMRMF, FSE: DH8C) Lomiko Metals Inc. announces that it’s participation of 20 % in Promethieus Technologies Inc. (“Promethieus Tech”) will be exchanged for 20 % equity in a new to be formed entity Promethieus Ventures N.V. (“Promethieus N.V.”).which intends to list on the Dutch Caribbean Securities Exchange (DCSX) N.V

The (DCSX) is a self-regulatory international exchange focused on the listing and trading of domestic and international securities. It is a securities exchange platform where companies can raise funding through a large network of global investors. The DCSX is focused on servicing start-ups as well as small and medium-sized enterprises.  The DCSX is located in Curacao, a Lesser Antilles island country in the southern Dutch Caribbean region.

Promethieus N.V. will seek to raise up to 10 million USD to advance the projects currently underway. The listing agent for Promethieus N.V. is Amergeris Global Listing and Exchange Services.  The company has requested and received the ticker symbol ‘TECH’ for Promethieus N.V.

Lomiko confirms that on July 31, 2019  it had entered into an agreement to sell it’s 100% interest in Lomiko Technologies Inc. to Promethieus Technologies Inc. (Canada) for $ 1,236,625 in return for a 20 % equity participation in Promethieus Tech. Lomiko subsequently provided an outline of reasons for the sale on November 25, 2019. Further, Lomiko  will be reimbursed $ 193,614.32 in expenses paid by Lomiko on behalf of Promethieus Tech.  This transaction was approved by shareholders of both Lomiko Metals Inc. and Promethieus Tech  Lomiko Technologies Inc. is the owner of 18.15% of SHD Smart Home Devices Ltd. and 40% of Graphene Energy Storage Devices.  Lomiko was a founding shareholder of Promethieus Tech and currently owns 20% of that company.  The transaction was reviewed by the applicable regulatory bodies.  The transaction was considered a non-arms length transaction as Mr. A. Paul Gill is a Director and a significant shareholder of all the entities involved.

As announced December 3, 2018, Promethieus Technologies Inc. changed it’s mandate to focus on Future Tech investments and has reviewed investment opportunities in electric vehicle infrastructure, clean energy, the Internet of Things (IoT) as well as clean-tech and green tech materials related to these technologies. 

For more information on Lomiko Metals, SHD Smart Home Devices or Promethieus, review the website at www.lomiko.com, www.shddevices.com and www.promethieus.com, contact A. Paul Gill at 604-729-5312 or email: [email protected]

On Behalf of the Board

“Jacqueline Michael”

Director, Chief Financial Officer

We seek safe harbor.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange), or the DCSX  accept responsibility for the adequacy or accuracy of this release.

A. Paul Gill
Lomiko Metals Inc. (TSX-V: LMR)
6047295312
[email protected]

Industry Bulletin: Goodbye To Diesel and Gasoline Cars: Volkswagen Factory Produces Last Ever Combustion Engine Car SPONSOR: Lomiko Metals $LMR.ca $CJC.ca $SRG.ca $NGC.ca $LLG.ca $GPH.ca $NOU.ca

Posted by AGORACOM-Eric at 3:30 PM on Wednesday, August 5th, 2020

SPONSOR: Lomiko Metals is focused on the exploration and development of minerals for the new green economy such as lithium and graphite. Lomiko has an option for 100% of the high-grade La Loutre graphite Property, Lac Des Iles Graphite Property and the 100% owned Quatre Milles Graphite Property. Lomiko is uniquely poised to supply the growing EV battery market. Click Here For More Information

  • Volkswagen factory in Zwickau only manufactures electric cars

The Volkswagen factory in Zwickau in Lower Saxony, Germany has seen its latest combustion car come out of its assembly line: the seventh-generation Golf R Estate. Vehicles have been built here since 1904, and iconic models such as the Trabant have emerged from its assembly line.

Today this plant will be dedicated exclusively to the assembly of electric cars, such as the Volkswagen ID.3 from November 2019, and in the future, it will also house the models of its sister brands SEAT and Audi.

the end of an era

Volkswagen

The German brand has said goodbye to combustion engines in Zwickau with this variant of the Golf, equipped with a 2.0-liter gasoline engine and finished in Oryx White Pearl Effect, which will go to a German customer.

With an investment of 1,200 million euros, the German manufacturer has been transforming Zwickau to make it the hub of its electrification plan. Once the final expansion phase is reached from 2021, it will produce six MEB platform models from three of the group’s brands, thanks to the 8,000 employees who work there in line with more than 1,600 robots that carry out assembly tasks.

The transformation works have already started in Hall 6, where Golf Estate has been produced until now. After a conversion phase that will last for several weeks during the summer, the first electric vehicles will be produced there at the end of the year, along with the ID.4, and an SUV from sister brand Audi is also planned.

The ID.3 electric motor, the 16-year-old dual-clutch gearboxes, and parts of the MEB modular platform leave the Kassel plant in the center of the Federal Republic of Germany.

Electric motors are manufactured here for all MEB vehicles in Europe and North America, and in parallel for the Chinese market. Parts of the battery box, shock absorbers, structural components, and the central tunnel are also developed and delivered to the Zwickau plant for assembly and thus complete the vehicle body.

For its part, the battery system for the ID.3 is manufactured in Brunswick alongside that of the Scania and MAN trucks.

As reported by the German brand, over the past 30 years, 6,049,207 Volkswagen cars of the Polo, Golf, Golf Estate, Passat Saloon, and Passat Variant models have been produced in Zwickau.

The Volkswagen ID.4 is the compact and 100% electric SUV that promises up to 500 km of autonomy

In 2017 Volkswagen presented its ID Crozz, a prototype electric SUV, in Shanghai. That concept has evolved and has now been integrated into this new ambitious transformation of the brand, which has reused the concept to present the Volkswagen ID.4.

It is an all-electric SUV in a contained format that, according to the firm, “will be produced and sold in Europe, China and the United States” and which joins Volkswagen ID.3 as the first exponents of this fully electric future that this manufacturer proposes.

Lots of autonomy for a compact SUV

One of the key points on which they have focused on the design of this compact SUV is that of aerodynamics. According to Volkswagen officials, this section is so advanced in ID.4 that it allows “to reduce the drag coefficient and that will manage to boost the autonomy of ID.4 to 500 kilometers, depending on the version .”

Volkswagen will first launch a rear-wheel-drive version to later develop the four-wheel-drive version. The maximum battery capacity is known to be 77 kWh and to be located “close to the center of the lower body to create a low center of gravity and optimal driving dynamics.”

The manufacturer also promises “interior space to spare” thanks to that compact electrical system and a fully digital dashboard controlled by both touch and voice gestures.

Production of the Volkswagen ID.3 began late last year, and the firm indicates that its production target for electric cars will be 1.5 million units by 2025 instead of the one million it intended to reach in its previous estimate. The new member of the family, the Volkswagen ID.4, is expected to present in Europe throughout 2020, and then launch in the United States as well.

SOURCE: https://vocal.media/wheel/goodbye-to-diesel-and-gasoline-cars-volkswagen-factory-produces-last-ever-combustion-engine-car-shifts-to-e-vs-only

Red Light Holland $TRIP.ca Commences Magic Truffles Growth Operation in the Netherlands, Months Ahead of Schedule $SHRM.ca $RVV.ca

Posted by AGORACOM-Eric at 8:42 AM on Wednesday, August 5th, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564679/hub/Red_Light_Holland_Logo_2.png

Toronto, Ontario–(Newsfile Corp. – August 5, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of a its brand of magic truffles to the legal, recreational market within the Netherlands (initially, in the form of its previously announced Microdosing Packs), is pleased to announce that it has expedited the build out of its approximately 3,000 square feet, custom built, indoor growing, production and distribution facility of the Company, in Horst, the Netherlands (the “Facility“) and has commenced growing its first crop of magic truffles.

“After careful research and planning, including working with our staff, consultants and contractors in the Netherlands and sourcing our truffles’ genetics, substrates and the proper equipment, Red Light Holland is ecstatic to announce that we have started to grow our first batch of magic truffles, much quicker than originally anticipated. This is another important milestone for the Company and we are quite proud to be moving along so quickly and efficiently,” said Todd Shapiro, Chief Executive Officer and Director of Red Light Holland.

Red Light Holland is currently growing three different strains of magic truffles, including Psilocybe Mexicana, Psilocybe Galindoi, and Psilocybe Tampanensis, and expects to have an initial batch of approximately 100,000 grams of magic truffles available in late October, 2020. Once ready, the magic truffles will be harvested over an approximate six week period, in order to be ready for internal testing and ultimately packaging and distribution within the Netherlands.

“This is an exciting day for the Company! I feel like cutting a ribbon to celebrate with our hard working team of consultants and growers behind the scenes who have helped get us to this point so rapidly. We have remained aggressive, despite COVID-19 slowdowns and Red Light Holland’s growth operation has officially begun,” added Hans Derix, President of Red Light Holland (who resides in Horst).

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws. The Company’s brand of magic truffles are expected to be sold in the Netherlands through existing Smart Shops as well as its e-commerce platform, and are expected to be initially made available in the form of its previously announced Microdosing Packs.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer and Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.comUnfollowRecommend

If you’re an investor in Aurora Cannabis $ACB Check out our recent interview with Avicanna $AVCN.ca

Posted by AGORACOM-JC at 5:25 PM on Tuesday, August 4th, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg

MEDICAL CANNABIS

  • Medical Cannabis 2.0 – Superior Products To Products Currently On The Market
    • Evidence Backed Medical Cannabis So Doctors Can Prescribe With Confidence
  • Launch Across Canada Immanent
  • Exclusive Distribution Through Online Store Of Shoppers Drug Mart
  • Global Distribution Through US, U.K, Australia, Colombia and Canada In H2 2020

We Can No Longer Ignore The Potential of Psychedelic Drugs To Treat Depression SPONSOR: Red Light Holland $TRIP.ca $SHRM.ca $RVV.ca

Posted by AGORACOM-Eric at 12:21 PM on Tuesday, August 4th, 2020
https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564679/hub/Red_Light_Holland_Logo_2.png

Sponsor: Red Light Holland’s goal is to grow, distribute and market a premium brand of magic truffles to the legal, recreational market within the Netherlands, and we can’t wait to shift the existing paradigm to direct further attention to the legal and responsible use of magic truffles. Click Here For More Info

  • At Imperial College we’ve been comparing psilocybin to conventional antidepressants – and the results are likely to be game-changing

The world is experiencing a devastating physical health emergency. But the coronavirus pandemic has also seen a renewed focus on our psychological wellbeing. Loneliness, uncertainty and grief may be intensifying an already acute mental health crisis, and in the US there has been a 20% spike in the number of prescriptions for antidepressant and anti-anxiety drugs during lockdown. Demand for key antidepressants is threatening to exceed supply in the UK – where prescriptions have already more than doubled over the last decade.

I head the Centre for Psychedelic Research at Imperial College London, the first of its kind, supported by about £3m in philanthropic donations. For 15 years, my research has focused on how drugs such as LSD, psilocybin, DMT and MDMA work in the brain, and how they may be useful in treating disorders such as depression. Like the present pandemic, a psychedelic drug experiences can be transformative – of the individual – and of society. Both illuminate the extent to which the condition of the world we inhabit is dependent on our own behaviours. And these, in turn, are a consequence of how we feel, think and perceive.

The Centre was founded in April 2019. A few months later, Johns Hopkins University in the US announced a supersized version, floated by $17m. If you have read Michael Pollan’s book How to Change Your Mind or seen the first episode of Gwyneth Paltrow’s Netflix series, The Goop Lab (titled The Healing Trip), you may be aware that such developments reflect a rising interest, and investment, in the mental health application of psychedelic drugs.

One reason for this is that a decades-long struggle to resurrect medical research in the area is beginning to bear fruit. In London, we have spearheaded work showing how psilocybin ( or “magic mushrooms”) can be used to assist psychotherapy for difficult-to-treat depression, making a significant difference when conventional antidepressants and talking therapy have not. Right now, we are crunching data from a much larger depression trial that compares psilocybin-assisted therapy with a six-week course of a conventional antidepressant drug, a “Prozac-like” selective serotonin reuptake inhibitor (SSRI). Preliminary analyses indicate game-changing results.

There hasn’t been a breakthrough in mental healthcare for some time, and psychedelic therapy works very differently to current treatments. Conventional drug treatments have dominated psychiatry for decades, and although many people prefer psychotherapy, it is more expensive, harder to access and arguably no more effective than the drugs.

These drugs haven’t changed much since their discovery, and come with side effects that put people off taking them. Where SSRIs are concerned, their antidepressant action seems to rely on a moderation of the stress response – but it is a palliative rather than curative action, which requires having the chemical in the body for several months or longer.

Psychedelic therapy is a much more comprehensive treatment package. It entails a small number of psychologically supported dosing sessions, flanked by assessment, preparation, and integration (talking through one’s experience afterwards). Psychedelics appear to increase brain “plasticity”, which, broadly speaking, implies an accelerated ability to change.

One view is that a psychedelic experience is a consequence of an especially intense surge of plasticity that opens a window of opportunity for lasting therapeutic change. The same windows may open up during other extreme states, such as experiencing trauma, stress-induced breakdown, a spontaneous spiritual experience or coming close to death. The difference with psychedelic therapy, however, is that the experience is carefully prepared for, contained and mediated. If not done this way, the use of psychedelics can be dangerous.

The impact of successful psychedelic therapy is often one of revelation or epiphany. People speak of witnessing “the bigger picture”, placing things in perspective, accessing deep insight about themselves and the world, releasing pent-up mental pain, feeling emotionally and physically recalibrated, clear-sighted and equanimous. This is very different from people’s descriptions of the effects of SSRIs, where a contrasting feeling of being emotionally muted is not uncommon. It would be premature to disclose the findings of our head-to-head trial prior to proper scientific review, but on top of impressive tolerability and antidepressant effects with psilocybin-assisted therapy, we are seeing remarkable changes in patient-relevant outcomes. These include increased quality of life, “flourishing” (feeling well rather than just “not depressed”), the ability to feel pleasure again and normal sexual functioning. The value of something new and different is often hard to gauge until it is placed alongside something more familiar, and our new study does this.

Those driving efforts to get psilocybin therapy licensed hope to be able to market it across North America and Europe within the next five years. As was the case with medicinal cannabis, however, it is quite possible that use could begin to scale up prior to formal licensing. Before Covid-19, a small but buoyant market existed for plant-based psychedelic retreats or ceremonies in pockets of Europe, as well as Central and South America. There have been a number of initiatives to liberalise policies on psychedelic use in the US, and the most ambitious is the psilocybin service initiative in Oregon, which aims to phase in legal, regulated psilocybin therapy through Oregon’s health system, from this year. Whatever one’s view on these developments, allying them with research is imperative if we are to advance scientific understanding, and ultimately inform and safeguard the individual.

Despite this progress, the idea of “psychedelics for mental health” will be petrol on flames for some. Stigma is attached to both mental illness and psychedelics, and so full entry into the mainstream won’t go unchallenged (and rightly so). If the 1960s is anything to go by, there may be passions to temper at both ends of the spectrum, as psychedelics evangelisers could stoke as much trouble as opponents – which is why a dispassionate, scientific approach is so important.

Like all tourism, the psychedelic variety will have taken a big hit in the pandemic, but it is unclear whether home use has been affected, either in prevalence or quality. “Hardly the best time for a trip,” one might think – but psychedelics are sensitive to the slippery subtleties of context. Many of the insights these compounds awaken are of a Buddhist sort, and although timelessly relevant, they feel particularly so today: the self as illusory, suffering as inevitable, attachment as a common cause of suffering, impermanence as fundamental, and slowing down, contemplation, breath, and community as potent resources.

Sars-Cov-2 is a virus that attacks the respiratory system and can kill. We all breathe, and we will all die, but our instinct is to forget and escape these truths. Two of this pandemic’s silver linings are that it has invited an expanded consciousness – and that people have slowed down. Many will have noticed their breath, contemplated their own and other’s impermanence, and felt grateful for care, love and life. If psychedelic therapy does fulfil its potential, it will be providing the same essential lessons. The extent to which we listen will be up to us.

SOURCE: https://www.theguardian.com/commentisfree/2020/jun/08/psychedelic-drugs-treat-depression

Gold’s Mega Rally Faces $2,000 Hurdle, But For How Long? SPONSOR: Candente Gold $CDG.ca $MEX.ca $AGI.ca

Posted by AGORACOM-Eric at 11:48 AM on Tuesday, August 4th, 2020

SPONSOR: Candente Gold is creating a growth strategy encompassing its Mexican assets to build a cash flowing business. Recent acquisition of the SDA Plant and the El Dorado Historic Mines is the first step. Their growth strategy is to build a cash flowing business platform and gain access to properties with near surface exploration potential while maintaining El Oro as its flagship asset, and an integral part of the overall growth strategy. El Oro is a district scale gold project encompassing a well-known prolific high-grade gold-silver epithermal vein system in Mexico that has several undeveloped veins and has tremendous exploration potential. Click Here for More Info

LONDON (Reuters) – Gold’s rally has halted just below $2,000 an ounce partly due to fierce technical resistance, but an eventual break above that level is likely, freeing prices for more record highs, technical analysts said.

The gold price XAU= has surged 30% this year to an all-time peak around $1,975 an ounce and is one of 2020’s best-performing assets.

The rally was driven by a belief that gold will hold its value better than other assets as fallout from COVID-19 ripples through the global economy.

Central bank stimulus has pushed inflation-adjusted U.S. bond yields to record lows, making non-yielding gold more attractive, and the dollar has weakened sharply, making bullion cheaper for buyers with other currencies.

The never-before-reached $2,000-an-ounce mark is a major psychological resistance level, with gold’s 49-year trend channel resting just below it at $1,983, said Commerzbank technical analyst Karen Jones.

Only an end-of-month or, better yet, end-of-quarter close above these levels will signal a break from the channel, she said.

“Tighten your stops … unless the top of my range is taken out in a convincing manner … upside from here is marginal.”

Graphic – Gold’s long-term channel: here

Technical analysts seek patterns and signals in price charts which allow them to predict and interpret moves. Traders and automated trading systems also take prompts from technical signals.

Because gold’s rally has been so fast, a downward correction is likely and could be brutal, analysts said, before the market attempts another stab higher.

Early support is coming in around its 20-day moving average, at $1,875, and the bottom of its 4-month uptrend, around $1,830.

Below that is more powerful support at the 20-week moving average, currently at $1,755, said Tom Pelc, an independent technical analyst formerly at Nomura and RBS.

Graphic – Gold technical support: here

Such a fall wouldn’t necessarily doom the longer-term uptrend.

“We continue to see this improving volatility backdrop, so there’s no sign that the long-term trend is changing,” said Richard Adcock, a former UBS and now independent technical analyst.

“The market can carry on higher than people expect,” he said.

Graphic – Gold price volatility: here

If resistance is broken, Fibonacci extensions offer short-term targets. These are based on the idea that a rally will extend in predictable proportions extrapolated from a previous rally. One is at $2,067, said Pelc, another comes in at $2,286.

Graphic – Gold fibonacci extension: here

That could only be the beginning of a multi-year move. Lucas ratios — a tool using a sequence of numbers similar to Fibonacci’s — suggest gold could rise to $3,598.80 an ounce in 4-5 years, said Pelc.

Reporting by Peter Hobson; Editing by Veronica Brown and Emelia Sithole-Matarise

https://www.kitco.com/news/2020-08-04/Gold-s-mega-rally-faces-2-000-hurdle-but-for-how-long.html

Datametrex $DM.ca Awarded Contract Extension With #USAirForce

Posted by AGORACOM-JC at 11:32 AM on Friday, July 31st, 2020
  • Successfully awarded a second contract in the United States defense industry, United States Air Force via Wright State Applied Research Corp. on July 29, 2020
  • WSARC is provides contracting, security and research administration services for Wright State Research Institute, the University and the state of Ohio, and will head the U.S. Air Force Academic Partnership and Engagement Experiment (APEX) program

TORONTO, July 31, 2020 – Datametrex AI Limited (the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G) is pleased to announce that it has been successfully awarded a second contract in the United States defense industry, United States Air Force via Wright State Applied Research Corp. (“WSARC”) on July 29, 2020. WSARC is provides contracting, security and research administration services for Wright State Research Institute, the University and the state of Ohio, and will head the U.S. Air Force Academic Partnership and Engagement Experiment (APEX) program.

“This is a great example of renewable business for Datametrex. Getting a one-year contract extension shows that our technology is valued by the client, and marks progress in our plan to expand our mandate with the organization. Datametrex will continue to solidify our position as a trusted solution provider within the U.S. military departments.” says Marshall Gunter, CEO of the Company.

The contract extension continues with the U.S. Air Force researchers at the Air Force Research Laboratory Airman Systems directorate. The Company is working with researchers within the USAF to land and expand, connecting different groups and finding new stakeholders that can benefit from our A.I. offering. The Air Force Research Laboratory’s Airman Systems Directorate is a vital component of the 711th Human Performance Wing. The directorate is composed of a diverse group of scientists and engineers studying developing technologies specific to the human element of warfighting capability.

The Air Force Research Laboratory (“AFRL”) is leading the discovery, development, and integration of affordable warfighting technologies for the U.S. Air and Space Force. AFRL is a scientific research organization operated by the United States Air Force Materiel Command dedicated to leading the discovery, development, and integrate biological and cognitive technologies to optimize and protect integration of affordable aerospace warfighting technologies, planning and executing the Air Force science and technology program, and providing warfighting capabilities to United States air, space, and cyberspace forces.

For more information on this project or to learn how Datametrex can assist your organization in social media discovery, Fake News Filters and BOT detection, please go to www.nexalogy.com

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational Health and Safety goals with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain.

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.